MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04551nam a22005777a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
181108s20192019 xxu||||| |||| 00| 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
|---|
| International Standard Serial Number |
0161-5505 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.2967/jnumed.118.213256 [doi] |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
jnumed.118.213256 [pii] |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
Ovid MEDLINE(R) |
| 099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
|---|
| PMID |
30361377 |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. |
| 251 ## - Source |
|---|
| Source |
Journal of Nuclear Medicine. 60(5):638-643, 2019 05. |
| 252 ## - Abbreviated Source |
|---|
| Abbreviated source |
J Nucl Med. 60(5):638-643, 2019 05. |
| 252 ## - Abbreviated Source |
|---|
| Former abbreviated source |
J Nucl Med. 2018 Oct 25 |
| 253 ## - Journal Name |
|---|
| Journal name |
Journal of nuclear medicine : official publication, Society of Nuclear Medicine |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Year |
2019 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Manufacturer |
FY2019 |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
aheadofprint |
| 265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
|---|
| Publication status |
ppublish |
| 266 ## - Date added to catalog |
|---|
| Date added to catalog |
2018-11-09 |
| 268 ## - Previous citation |
|---|
| -- |
Journal of Nuclear Medicine. 2018 Oct 25 |
| 501 ## - WITH NOTE |
|---|
| Local holdings |
Available online from MWHC library: 1964 - present, Available in print through MWHC library: 1999 - 2006 |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
<b>Rationale:</b> Patients treated with <sup>131</sup>I may be identified at security checkpoints at various public facilities. The objective of this survey was to determine the frequency of detection, spectrum of public facilities, the various management of these patients by security agents, and the spectrum of physician documentation for the patient regarding his/her <sup>131</sup>I therapy. <b>Methods:</b> Data were tabulated from a ThyCa: Thyroid Cancer Survivors' Association, Inc. (ThyCa) survey emailed to ~15,000 associates and available online from Dec 2013 to Dec 2014. Responses were tabulated from respondents who reported that they were >18 yo, had at least one therapy of <sup>131</sup>I for differentiated thyroid cancer, and were responding regarding their last <sup>131</sup>I therapy. <b>Results:</b> Of 621 respondents, 595 reported an attempt to pass through a public facility security checkpoint. Of these 595 pts, 9.6%(57) were identified as being radioactive, and of 43 respondents, the facility was an airport in 35%(15), border crossing in 33%(14), government building in 19%(8), shopping mall in 7%(3), train station in 5%(2), and steel recycling plant in 2%(1). Of 47 respondents, the security agent's management of the patient included questioning 38%(81), allowing to proceed without a change in travel plans 57%(27), requesting documentation of the therapy 55%(26), rescanning 55%(26), calling a member of the treating team for validation 17%(8), "strip" searching 4%(2), detaining such that a change in travel plans was required 6%(3), and/or prohibiting continued travel for 4%(2). Of 47 respondents, they were detained from <30 min 57%(27), 30-<60 min 21%(10), 1-<1.5 hrs 15%(7), 1.5- <2hrs 2%(1), 2-4 hrs 0%(0), > 4 hrs 4%(2). Data regarding physician documentation are presented <b>Conclusion:</b> Detection of radioactivity in public facilities after 131 I therapy occurred in 9.6% of patient-respondents in a variety of security checkpoints. Travel inconvenience is not infrequent and may require altering travel plans. Physicians should take steps to assure that patients not only have appropriate documentation of their <sup>131</sup>I therapy with them but also have instructions regarding how the security agent may verify the patients' <sup>131</sup>I therapy. |
| 520 ## - SUMMARY, ETC. |
|---|
| Abstract |
Copyright (c) 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc. |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Documentation |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Iodine Radioisotopes/an [Analysis] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Iodine Radioisotopes/tu [Therapeutic Use] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Physicians |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Public Facilities |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Security Measures |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
*Thyroid Neoplasms/rt [Radiotherapy] |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Humans |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Thyroid Neoplasms/pa [Pathology] |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Health Research Institute |
| 651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
|---|
| Institution |
MedStar Washington Hospital Center |
| 656 ## - INDEX TERM--OCCUPATION |
|---|
| Department |
Medicine/Endocrinology |
| 656 ## - INDEX TERM--OCCUPATION |
|---|
| Department |
Medicine/Nuclear Medicine |
| 657 ## - INDEX TERM--FUNCTION |
|---|
| Medline publication type |
Journal Article |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Bethancourt, Evelyn |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Bikas, Athanasios |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Burman, Kenneth D |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Orquiza, Michael |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Van Nostrand, Douglas |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Wartofsky, Leonard |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Local Authors |
Wu, Di |
| 790 ## - Authors |
|---|
| All authors |
Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| DOI |
<a href="https://dx.doi.org/10.2967/jnumed.118.213256">https://dx.doi.org/10.2967/jnumed.118.213256</a> |
| Public note |
https://dx.doi.org/10.2967/jnumed.118.213256 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Journal Article |
| Item type description |
Article |
